» Articles » PMID: 33374558

Global Genome Demethylation Causes Transcription-Associated DNA Double Strand Breaks in HPV-Associated Head and Neck Cancer Cells

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2020 Dec 30
PMID 33374558
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

High levels of DNA methylation at CpG loci are associated with transcriptional repression of tumor suppressor genes and dysregulation of DNA repair genes. Human papilloma virus (HPV)-associated head and neck squamous cell carcinomas (HNSCC) have high levels of DNA methylation and methylation has been associated with dampening of an innate immune response in virally infected cells. We have been exploring demethylation as a potential treatment in HPV+ HNSCC and recently reported results of a window clinical trial showing that HNSCCs are particularly sensitive to demethylating agent 5-azacytidine (5-aza). Mechanistically, sensitivity is partially due to downregulation of HPV genes expression and restoration of tumor suppressors p53 and Rb. Here, for the first time, we show that 5-azaC treatment of HPV+ HNSCC induces replication and transcription-associated DNA double strand breaks (DSBs) that occur preferentially at demethylated genomic DNA. Blocking replication or transcription prevented formation of DNA DSBs and reduced sensitivity of HPV-positive head and neck cancer cells to 5-azaC, demonstrating that both replication and active transcription are required for formation of DSBs associated with 5-azaC.

Citing Articles

De-Escalated Therapy and Early Treatment of Recurrences in HPV-Associated Head and Neck Cancer: The Potential for Biomarkers to Revolutionize Personalized Therapy.

Yarbrough W, Schrank T, Burtness B, Issaeva N Viruses. 2024; 16(4).

PMID: 38675879 PMC: 11053602. DOI: 10.3390/v16040536.


Global DNA Methylation Level in Tumour and Margin Samples in Relation to Human Papilloma Virus and Epstein-Barr Virus in Patients with Oropharyngeal and Oral Squamous Cell Carcinomas.

Gazdzicka J, Biernacki K, Golabek K, Miskiewicz-Orczyk K, Zieba N, Misiolek M Biomedicines. 2024; 12(4).

PMID: 38672268 PMC: 11047928. DOI: 10.3390/biomedicines12040914.


DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival.

Papalouka C, Adamaki M, Batsaki P, Zoumpourlis P, Tsintarakis A, Goulielmaki M Int J Mol Sci. 2023; 24(3).

PMID: 36769087 PMC: 9917521. DOI: 10.3390/ijms24032760.


Exploring ABOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer.

Papini C, Wang Z, Kudalkar S, Schrank T, Tang S, Sasaki T iScience. 2022; 25(10):105077.

PMID: 36164654 PMC: 9508485. DOI: 10.1016/j.isci.2022.105077.


Direct Comparison of HPV16 Viral Genomic Integration, Copy Loss, and Structural Variants in Oropharyngeal and Uterine Cervical Cancers Reveal Distinct Relationships to E2 Disruption and Somatic Alteration.

Schrank T, Kim S, Rehmani H, Kothari A, Wu D, Yarbrough W Cancers (Basel). 2022; 14(18).

PMID: 36139648 PMC: 9496734. DOI: 10.3390/cancers14184488.


References
1.
. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; 517(7536):576-82. PMC: 4311405. DOI: 10.1038/nature14129. View

2.
Chera B, Amdur R, Green R, Shen C, Gupta G, Tan X . Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. J Clin Oncol. 2019; 37(29):2661-2669. PMC: 7010421. DOI: 10.1200/JCO.19.01007. View

3.
Daskalakis M, Nguyen T, Nguyen C, Guldberg P, Kohler G, Wijermans P . Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment. Blood. 2002; 100(8):2957-64. DOI: 10.1182/blood.V100.8.2957. View

4.
Dong Y, Ridge J, Ebersole B, Li T, Lango M, Churilla T . Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer. Oral Oncol. 2019; 95:59-64. PMC: 7747216. DOI: 10.1016/j.oraloncology.2019.05.014. View

5.
Schneider-Stock R, Diab-Assef M, Rohrbeck A, Foltzer-Jourdainne C, Boltze C, Hartig R . 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms. J Pharmacol Exp Ther. 2004; 312(2):525-36. DOI: 10.1124/jpet.104.074195. View